Page 99 - Quest Diagnostics News Today

Alpine Woods Capital Investors LLC reduced its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 16.9% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 58,609 shares of the medical research company’s stock after selling 11,895 shares during the quarter. Quest Diagnostics makes […]

Global Biopsy Devices Market report, businesses can acquire details about market drivers and market restraints which help them to guess about reducing or growing the production of particular product. It also offers top to bottom examination of the market for estimating income, return on investment (ROI) and developi...

Cambiar Investors LLC increased its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 20.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,988 shares of the medical research company’s stock after buying an additional 11,848 shares […]

/PRNewswire/ -- The "United States DTC Wellness Testing Market - By Test Type, Offerings, Distribution Channel, Sample Type, Region, Competition, Opportunity,...

The National Institute on Aging and the Alzheimer’s Association have proposed revised clinical guidelines that would designate seven major stages of the brain disease.

UNIVEST FINANCIAL Corp trimmed its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 8.7% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 1,677 shares of the medical research company’s stock after selling 159 shares during the period. UNIVEST FINANCIAL Corp’s holdings in Quest Diagnostics were […]

Blood tests for Alzheimer’s risk are finally here, so what are the pros and cons of taking a test?

'Patients will have a difficult time knowing what the results mean'

Five major U.S. health systems said they would offer Eisai and Biogens promising new Alzheimers drug Leqembi after working out payment and administrative policies, and how to assess and monitor patients, most likely in the next month or two.

People can purchase a blood test online to detect their risk for Alzheimer's disease. The test does not need a doctor's visit or prior authorization.